Public Health England
London, SE1, United Kingdom
NCT Number: NCT03862794
This trial aims to reduce unnecessary prescription of antibiotics and broad spectrum antibiotics by general practitioners (GPs) in England. Unnecessary prescriptions are defined as those that do not improve patient health outcomes. The intervention is to send GPs a letter from the Chief Medical Officer (CMO) that gives feedback on their practice's prescribing levels. Specifically the sample was GPs whose practices whose prescribed more than 1.161 items per STAR-PU or whose practices prescribed more that .965 items per STAR-PU and greater than 10% broad spectrum items. The intervention groups received a letter telling them they are among the highest prescribers of either their total or broad spectrum antibiotics, with a graph showing their prescribing compared to average prescribing ("their peers"). The letter also contained a leaflet to help GPs discuss self-care advice with patients and some advice to use delayed prescriptions. The investigators hypothesize that the antibiotic prescribing rate in will be lower for the treatment group compared to the control group, following the receipt of the letter.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
London, SE1, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
letter with the percentile prescribing the practice is on and a bar chart, comparing prescribing to the national average
social norm feedback letter used as standard practice, without specific information about the prescribing percentile
Time frame: 1 month
antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)
Time frame: 1 month
broad spectrum antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)
Time frame: 1 month
percentage broad spectrum antibiotic prescribing
Time frame: 1 month
total overall antibiotic prescribing minus total broad spectrum antibiotic prescribing
Time frame: 2 months
antibiotic prescribing weighted by Specific Therapeutic group Age-sex Related Prescribing Unit (STAR-PU)
Time frame: 2 months
Time frame: 2 months
Time frame: 2 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: 4 months
Time frame: 4 months
Time frame: 4 months
Time frame: 4 months
Time frame: 5 months
Time frame: 5 months
Time frame: 5 months
Time frame: 5 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Time frame: 6 months
Public Health England
Other Gov
A Randomized Controlled Trial of Behaviourally Informed Feedback Letters Sent by the Chief Medical Officer on the Amount of Antibiotics and the Percentage of Broad Spectrum Antibiotics Prescribed in Primary Care
Acronym: CMO2018-9
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05172687
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04051281
Prescribing, Off-Label
London, United Kingdom
View Trial DetailsNCT03582072
Prescribing, Off-Label
London, United Kingdom
View Trial Details